Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Factor This
This Week in Cleantech
Factor This Policycast
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Factor This
Factor This Policycast
This Week in Cleantech
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ensysce Biosciences, Inc. - Common Stock
(NQ:
ENSC
)
0.2826
-0.0088 (-3.02%)
Streaming Delayed Price
Updated: 9:59 AM EDT, Jul 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ensysce Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Crude Oil Moves Higher; Dollar General Earnings Miss Estimates
↗
August 29, 2024
Via
Benzinga
Topics
Earnings
Nasdaq Surges Over 1%; Best Buy Posts Upbeat Earnings
↗
August 29, 2024
Via
Benzinga
Ensysce Biosciences (ENSC) Stock Is Down 30% Today: What's Going On?
↗
August 29, 2024
Ensysce Biosciences shares are trading lower by 30% during Thursday's session. The company announced a $5 million registered direct offering and concurrent private placement.
Via
Benzinga
Dow Jumps Over 100 Points; Nvidia Earnings Top Views
↗
August 29, 2024
Via
Benzinga
Topics
Stocks
Ensysce Biosciences, Inc. Announces $5 Million Concurrent Registered Direct Offering and Exercise of Warrants
August 29, 2024
Via
ACCESSWIRE
Ensysce Biosciences Announces IRB Approval for Key MPAR Study
August 27, 2024
Via
ACCESSWIRE
Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
↗
August 28, 2024
Via
Benzinga
S&P 500 Edges Higher; American Woodmark Shares Slide
↗
August 27, 2024
Via
Benzinga
Topics
Stocks
Crude Oil Dips; Addex Therapeutics Shares Spike Higher
↗
August 27, 2024
Via
Benzinga
US Stocks Mixed; ScanSource Reports Weak Q4 Results
↗
August 27, 2024
Via
Benzinga
Ensysce Biosciences Provides Key Themes Following IASP 2024 Symposium
August 06, 2024
Via
ACCESSWIRE
Ensysce Biosciences Provides Mid-Year 2024 Update
July 23, 2024
Via
ACCESSWIRE
Ensysce Biosciences Hosts IASP 2024 Symposium and Presents Clinical Dataset
July 09, 2024
Via
ACCESSWIRE
Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting
June 27, 2024
Via
ACCESSWIRE
ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q2 2024
↗
August 14, 2024
ENSC stock results show that Ensysce Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Ensysce Biosciences Reports Second Quarter 2024 Financial Results
August 14, 2024
Via
ACCESSWIRE
Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate
June 25, 2024
Via
ACCESSWIRE
ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q1 2024
↗
June 24, 2024
ENSC stock results show that Ensysce Biosciences beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
↗
June 21, 2024
Via
Benzinga
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
June 06, 2024
Via
ACCESSWIRE
Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting
June 03, 2024
Via
ACCESSWIRE
Ensysce Biosciences Reports First Quarter 2024 Financial Results
May 13, 2024
Via
ACCESSWIRE
Ensysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge Magazine
April 25, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
June 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 18, 2024
Via
Benzinga
Ensysce Biosciences Regains Compliance with Nasdaq
May 28, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 23, 2024
Via
Benzinga
Ensysce Biosciences' Presentation from the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference Published
April 19, 2024
Via
ACCESSWIRE
Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform
May 20, 2024
Via
ACCESSWIRE
Ensysce Biosciences to Participate in the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
April 09, 2024
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
